̽»¨¾«Ñ¡

Gabriel Oniscu is a transplant surgeon with a clinical focus on multi-organ transplantation and living kidney donation. He graduated from the University of Medicine of Iasi, Romania and has completed his surgical and transplant training in Edinburgh, Birmingham, King’s College Hospital, London and Assan Medical Centre Seoul and obtained a doctorate from the University of Edinburgh.

Until 2022 he was the Director of the Edinburgh Transplant Centre, lead clinician for novel organ perfusion and preservation technologies and Transplant Advisor to the Chief Medical Officer in Scotland.

Gabriel Oniscu is also the President-of the European Society for Organ Transplantation

Gabriel has a particular clinical and research interest in novel organ perfusion and preservation technologies to improve transplant outcomes and has been one of the pioneers in the field in the UK. He is also using novel machine perfusion technologies as a platform for better organ assessment prior to transplantation and for the testing and delivery of organ repair therapies such as senolytic drugs or human biliary epithelial cells to induce organ repair and reconditioning. In collaboration with engineering teams his research also focused on the development of real-time non-invasive optical imaging technology to analise the biomolecular composition of liver tissue and bile.

Gabriel's second research interest is access to transplantation and transplant outcomes. He was one of the lead investigators in the NIHR funded study Access to Tranplantation and Transplant Outcome Measures (ATTOM) that explored socio-economic and health literacy factors in renal transplantation in the UK.